Short Communication

Journal of Human Genetics (2001) 46, 152–154; doi:10.1007/s100380170104

A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene

Dongqing Wang1, Bingquan Wu1, Yan Li1, Wanjie Heng1, Haohao Zhong1, Ying Mu2 and Jiajin Wang2

  1. 1Department of Pathology, Medical Department of Peking University, 38 Xueyuan Road, Beijing, P.R. China
  2. 2Department of Heredity, The People's Hospital, Peking University, Beijing, P.R. China

Correspondence: Dongqing Wang, Department of Pathology, Medical Department of Peking University, 38 Xueyuan Road, Beijing, P.R. China. Fax: +86-010-62091406. E-mail:

Received 30 October 2000; Accepted 18 December 2000.



Familial hypercholesterolemia (FH) is an autosomal dominant disorder caused by mutations in the low-density lipoprotein receptor (LDLR) gene; it is characterized by a high concentration of LDL, which frequently gives rise to tendon xanthomas and premature coronary artery disease (CAD). Individuals with heterozygous FH in China often exhibit a milder phenotype than those in other countries. The diagnosis of heterozygous FH relies on the clinical phenotype and this does not always permit unequivocal diagnosis of the disease. In the course of investigation of FH in a Chinese population sample, we found a family whose proband showed a markedly raised concentration of LDL cholesterol in plasma, and the presence of skin and tendon xanthomata. We used single-strand conformation polymorphism (SSCP) analysis to screen all the 18 exons and the exon-intron boundaries of the LDLR gene. One novel homozygous mutation, replacing T by C at nucleotide 850 in exon 6 was identified. This change substituted cysteine for arginine at codon 263 (C263R) of the LDLR. By means of mutant allele-specific amplification, we unequivocally diagnosed six heterozygotes with this novel mutation in the proband's family.


Familial hypercholesterolemia, LDL receptor, Lipoproteins, Mutations, Phenotype